Tech Company Financing Transactions
Quris Funding Round
Welltech Ventures, GlenRock Israel and iAngels participated in a $28 million Seed funding round for Quris. The round was announced by the company on 1/25/2022.
Transaction Overview
Company Name
Announced On
1/25/2022
Transaction Type
Venture Equity
Amount
$28,000,000
Round
Seed
Investors
Proceeds Purpose
The funding will fast-track Quris' novel drug research and development, team expansion and partner-building efforts as it scales to rapidly scan 100s of drug candidates to train its AI engine in its mission to revolutionize the drug development process.
Company Information
Company Status
Private & Independent
Industry
Artificial Intelligence
Mailing Address
114 Yigal Alon St.
Tel-Aviv, Undisclosed
Israel
Tel-Aviv, Undisclosed
Israel
Phone
Undisclosed
Website
Email Address
Overview
Quris is an artificial intelligence innovator that is disrupting the drug development process. Quris's Bio-AI Clinical Prediction Platform better predicts which drug candidates will safely work in humans, avoiding tremendous costs of failed clinical trials.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chairman
Amir Alush
Chief Executive Officer
Isaac Bentwich
Chief Financial Officer
Jeremy Rome
Chief Technical Officer
Yossi Haran
Vice President
Amir Bein
VP - Bus. Development
Shani Weiss
Browse more venture capital transactions:
Prev: 1/23/2022: ShopThing venture capital transaction
Next: 1/25/2022: Bolt Financial venture capital transaction
Share this article
Where The Data Comes From
We do our best to document every notable VC transaction. All VC database entries reported here are sourced from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs